Sanofi Ventures

Activity in this selectionEnterprise software

By stage

Series A2

Series B2

Series C+1

Biotech4

Healthtech1

United States2

France1

Israel1

United Kingdom1

5 in this selection

Aug 10

Develops programmable epigenetic medicines to treat genetic diseases like FSHD

$90MSeries C

Role not disclosed

Aug 4

AI-driven platform that simulates clinical trials to predict outcomes before patient enrollment

$45MSeries B

Role not disclosed

Jul 14

Developing transformative, best-in-class neuropsychiatric therapies

$65MSeries B

Role not disclosed

Jun 22

Developing next-generation biologics for severe immunological and inflammatory diseases

$165MSeries A

Role not disclosed

May 13

Builds AI platform helping pharma companies identify, activate and optimize patient and HCP audiences

$26MSeries A

Role not disclosed